Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent T Ho

Showing results (81-90 of 227) with videos related to

Pageof 23
Sort By:
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|August 22, 2017
Oral health status and risk of bacteremia following allogeneic hematopoietic cell transplantationAhmed S Sultan, Yvette Zimering, Gloria Petruzziello, et al.
American Journal of Hematology|April 5, 2012
Does iron overload really matter in stem cell transplantation?Philippe Armand, Marie-Michele Sainvil, Haesook T Kim, et al.
Haematologica|April 10, 2025
Reduced incidence of relapse and graft-<i>versus</i>-host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantationHaesook T Kim, Robert J Soiffer, Corey Cutler, et al.
The New England Journal of Medicine|September 2, 2011
Cord colitis syndrome in cord-blood stem-cell transplantationAlex F Herrera, Gabriela Soriano, Andrew M Bellizzi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and ReactogenicityAmy C Sherman, Michaël Desjardins, Chi An Cheng, et al.
Blood|March 30, 2007
Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysisFrancisco M Marty, Julie Bryar, Sarah K Browne, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 7, 2018
Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell TransplantationLindsey E Roeker, Haesook T Kim, Brett Glotzbecker, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2018
A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort AnalysisMahasweta Gooptu, Haesook T Kim, Vincent T Ho, et al.
Haematologica|June 30, 2016
A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantationSarah Nikiforow, Haesook T Kim, Heather Daley, et al.
Haematologica|January 16, 2016
Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantationPaul S Martin, Shuli Li, Sarah Nikiforow, et al.
Pageof 23

Showing results (81-90 of 227) with videos related to

Sort By:
Pageof 23
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|August 22, 2017
Oral health status and risk of bacteremia following allogeneic hematopoietic cell transplantationAhmed S Sultan, Yvette Zimering, Gloria Petruzziello, et al.
American Journal of Hematology|April 5, 2012
Does iron overload really matter in stem cell transplantation?Philippe Armand, Marie-Michele Sainvil, Haesook T Kim, et al.
Haematologica|April 10, 2025
Reduced incidence of relapse and graft-<i>versus</i>-host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantationHaesook T Kim, Robert J Soiffer, Corey Cutler, et al.
The New England Journal of Medicine|September 2, 2011
Cord colitis syndrome in cord-blood stem-cell transplantationAlex F Herrera, Gabriela Soriano, Andrew M Bellizzi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and ReactogenicityAmy C Sherman, Michaël Desjardins, Chi An Cheng, et al.
Blood|March 30, 2007
Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysisFrancisco M Marty, Julie Bryar, Sarah K Browne, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 7, 2018
Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell TransplantationLindsey E Roeker, Haesook T Kim, Brett Glotzbecker, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2018
A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort AnalysisMahasweta Gooptu, Haesook T Kim, Vincent T Ho, et al.
Haematologica|June 30, 2016
A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantationSarah Nikiforow, Haesook T Kim, Heather Daley, et al.
Haematologica|January 16, 2016
Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantationPaul S Martin, Shuli Li, Sarah Nikiforow, et al.
Pageof 23